| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.198 | 30.929 | 30.483 | 32.631 | 35.245 | 34.493 | 38.897 | 40.729 | 45.967 | 47.733 |
| Total Income - EUR | 32.636 | 30.929 | 30.483 | 32.631 | 37.141 | 38.215 | 38.907 | 40.769 | 45.981 | 47.733 |
| Total Expenses - EUR | 4.617 | 6.514 | 4.654 | 2.967 | 6.083 | 7.132 | 9.072 | 8.299 | 3.737 | 6.465 |
| Gross Profit/Loss - EUR | 28.019 | 24.414 | 25.829 | 29.665 | 31.058 | 31.082 | 29.835 | 32.471 | 42.244 | 41.268 |
| Net Profit/Loss - EUR | 27.319 | 23.838 | 25.060 | 28.686 | 30.001 | 30.573 | 29.446 | 32.063 | 35.485 | 36.139 |
| Employees | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Med Int Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.398 | 673 | 249 | 93 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 47.465 | 46.985 | 50.897 | 60.239 | 63.246 | 60.549 | 65.956 | 66.263 | 84.128 | 38.163 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 43.696 | 45.745 | 50.662 | 56.156 | 58.984 | 55.597 | 54.583 | 61.436 | 77.485 | 27.832 |
| Cash | 3.769 | 1.241 | 234 | 4.083 | 4.262 | 4.952 | 11.373 | 4.827 | 6.643 | 10.332 |
| Shareholders Funds | 43.446 | 39.801 | 40.753 | 44.090 | 45.107 | 45.394 | 43.937 | 46.600 | 81.943 | 37.211 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.416 | 7.857 | 10.393 | 16.242 | 18.139 | 15.155 | 22.019 | 19.664 | 2.185 | 952 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Med Int Srl